COGT Annual CFO
-$153.62 M
-$34.99 M-29.49%
31 December 2023
Summary:
As of January 23, 2025, COGT annual cash flow from operations is -$153.62 million, with the most recent change of -$34.99 million (-29.49%) on December 31, 2023. During the last 3 years, it has fallen by -$117.77 million (-328.52%). COGT annual CFO is now -967.15% below its all-time high of $17.72 million, reached on December 31, 2015.COGT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT Quarterly CFO
-$51.98 M
-$9.28 M-21.74%
30 September 2024
Summary:
As of January 23, 2025, COGT quarterly cash flow from operations is -$51.98 million, with the most recent change of -$9.28 million (-21.74%) on September 30, 2024. Over the past year, it has dropped by -$9.28 million (-21.74%). COGT quarterly CFO is now -802.34% below its all-time high of -$5.76 million, reached on June 30, 2017.COGT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT TTM CFO
-$191.28 M
-$14.01 M-7.90%
30 September 2024
Summary:
As of January 23, 2025, COGT TTM cash flow from operations is -$191.28 million, with the most recent change of -$14.01 million (-7.90%) on September 30, 2024. Over the past year, it has dropped by -$14.01 million (-7.90%). COGT TTM CFO is now -2531.87% below its all-time high of -$7.27 million, reached on March 31, 2017.COGT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.5% | -21.7% | -7.9% |
| 3 y3 years | -328.5% | -268.4% | -304.0% |
| 5 y5 years | -372.9% | -524.5% | -448.6% |
COGT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -161.4% | at low | -150.2% | +1.0% | -225.5% | at low |
| 5 y | 5-year | -328.5% | at low | -558.6% | +1.0% | -448.6% | at low |
| alltime | all time | -967.1% | at low | -802.3% | +1.0% | -2531.9% | at low |
Cogent Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$51.98 M(+21.7%) | -$191.28 M(+7.9%) |
| June 2024 | - | -$42.70 M(-18.7%) | -$177.27 M(+6.4%) |
| Mar 2024 | - | -$52.53 M(+19.2%) | -$166.64 M(+8.5%) |
| Dec 2023 | -$153.62 M(+29.5%) | -$44.07 M(+16.1%) | -$153.62 M(+10.6%) |
| Sept 2023 | - | -$37.97 M(+18.4%) | -$138.96 M(+2.6%) |
| June 2023 | - | -$32.07 M(-18.9%) | -$135.43 M(+4.3%) |
| Mar 2023 | - | -$39.52 M(+34.4%) | -$129.82 M(+9.4%) |
| Dec 2022 | -$118.64 M(+101.9%) | -$29.41 M(-14.6%) | -$118.64 M(+7.8%) |
| Sept 2022 | - | -$34.44 M(+30.2%) | -$110.01 M(+22.7%) |
| June 2022 | - | -$26.46 M(-6.6%) | -$89.68 M(+18.4%) |
| Mar 2022 | - | -$28.33 M(+36.4%) | -$75.73 M(+28.9%) |
| Dec 2021 | -$58.76 M(+63.9%) | -$20.78 M(+47.3%) | -$58.76 M(+24.1%) |
| Sept 2021 | - | -$14.11 M(+12.8%) | -$47.35 M(+8.8%) |
| June 2021 | - | -$12.51 M(+10.1%) | -$43.51 M(+10.6%) |
| Mar 2021 | - | -$11.37 M(+21.4%) | -$39.32 M(+9.7%) |
| Dec 2020 | -$35.85 M | -$9.37 M(-8.8%) | -$35.85 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$10.27 M(+23.3%) | -$34.93 M(+0.2%) |
| June 2020 | - | -$8.32 M(+5.5%) | -$34.87 M(-8.0%) |
| Mar 2020 | - | -$7.89 M(-6.5%) | -$37.89 M(-8.7%) |
| Dec 2019 | -$41.51 M(+27.8%) | -$8.45 M(-17.3%) | -$41.51 M(-1.4%) |
| Sept 2019 | - | -$10.21 M(-10.0%) | -$42.09 M(+6.7%) |
| June 2019 | - | -$11.34 M(-1.5%) | -$39.46 M(+9.5%) |
| Mar 2019 | - | -$11.52 M(+27.7%) | -$36.03 M(+10.9%) |
| Dec 2018 | -$32.49 M(+25.8%) | -$9.02 M(+19.1%) | -$32.49 M(+8.4%) |
| Sept 2018 | - | -$7.58 M(-4.3%) | -$29.98 M(+4.5%) |
| June 2018 | - | -$7.91 M(-0.9%) | -$28.70 M(+8.1%) |
| Mar 2018 | - | -$7.98 M(+22.5%) | -$26.55 M(+2.8%) |
| Dec 2017 | -$25.84 M(+38.6%) | -$6.52 M(+3.6%) | -$25.84 M(+33.7%) |
| Sept 2017 | - | -$6.29 M(+9.2%) | -$19.32 M(+48.3%) |
| June 2017 | - | -$5.76 M(-20.7%) | -$13.03 M(+79.3%) |
| Mar 2017 | - | -$7.27 M | -$7.27 M |
| Dec 2016 | -$18.64 M(-205.2%) | - | - |
| Dec 2015 | $17.72 M | - | - |
FAQ
- What is Cogent Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Cogent Biosciences?
- What is Cogent Biosciences annual CFO year-on-year change?
- What is Cogent Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cogent Biosciences?
- What is Cogent Biosciences quarterly CFO year-on-year change?
- What is Cogent Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Cogent Biosciences?
- What is Cogent Biosciences TTM CFO year-on-year change?
What is Cogent Biosciences annual cash flow from operations?
The current annual CFO of COGT is -$153.62 M
What is the all time high annual CFO for Cogent Biosciences?
Cogent Biosciences all-time high annual cash flow from operations is $17.72 M
What is Cogent Biosciences annual CFO year-on-year change?
Over the past year, COGT annual cash flow from operations has changed by -$34.99 M (-29.49%)
What is Cogent Biosciences quarterly cash flow from operations?
The current quarterly CFO of COGT is -$51.98 M
What is the all time high quarterly CFO for Cogent Biosciences?
Cogent Biosciences all-time high quarterly cash flow from operations is -$5.76 M
What is Cogent Biosciences quarterly CFO year-on-year change?
Over the past year, COGT quarterly cash flow from operations has changed by -$9.28 M (-21.74%)
What is Cogent Biosciences TTM cash flow from operations?
The current TTM CFO of COGT is -$191.28 M
What is the all time high TTM CFO for Cogent Biosciences?
Cogent Biosciences all-time high TTM cash flow from operations is -$7.27 M
What is Cogent Biosciences TTM CFO year-on-year change?
Over the past year, COGT TTM cash flow from operations has changed by -$14.01 M (-7.90%)